Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Teng

Showing results (271-280 of 301) with videos related to

Pageof 31
Sort By:
Dermatology and Therapy|May 11, 2023
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL StudyKalyani Marathe, Joyce M C Teng, Scott Guenthner, et al.
Clinical and Experimental Dermatology|February 16, 2023
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosisDedee F Murrell, Joyce M C Teng, Scott Guenthner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 20, 2007
Suppressed neuronal activity and concurrent arteriolar vasoconstriction may explain negative blood oxygenation level-dependent signalAnna Devor, Peifang Tian, Nozomi Nishimura, et al.
Clinical and Experimental Dermatology|March 17, 2023
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL studyChristopher G Bunick, Joyce M C Teng, Scott Guenthner, et al.
American Journal of Medical Genetics. Part A|March 13, 2016
RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndromeColleen F Macmurdo, Whitney Wooderchak-Donahue, Pinar Bayrak-Toydemir, et al.
JAMA Dermatology|July 17, 2014
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus StatementsJoyce M C Teng, Edward W Cowen, Mari Wataya-Kaneda, et al.
Medical Mycology Case Reports|September 29, 2021
<i>Prototheca wickerhamii</i> breast implant infection after reconstructive surgery: a new level of complexityJoanne S K Teh, Amalie E Wilke, Simon M Overstall, et al.
Biochemistry|June 12, 1998
A mutational analysis of binding interactions in an antigen-antibody protein-protein complexW Dall'Acqua, E R Goldman, W Lin, et al.
Journal of the American Academy of Dermatology|July 25, 2022
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosisJoyce M C Teng, Christopher G Bunick, Scott Guenthner, et al.
JCO Clinical Cancer Informatics|June 16, 2026
Development of a Digital Phenotype for Immune-Related ColitisJasmine C Teng, Leon J Worth, Karin A Thursky, et al.
Pageof 31

Showing results (271-280 of 301) with videos related to

Sort By:
Pageof 31
Dermatology and Therapy|May 11, 2023
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL StudyKalyani Marathe, Joyce M C Teng, Scott Guenthner, et al.
Clinical and Experimental Dermatology|February 16, 2023
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosisDedee F Murrell, Joyce M C Teng, Scott Guenthner, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 20, 2007
Suppressed neuronal activity and concurrent arteriolar vasoconstriction may explain negative blood oxygenation level-dependent signalAnna Devor, Peifang Tian, Nozomi Nishimura, et al.
Clinical and Experimental Dermatology|March 17, 2023
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL studyChristopher G Bunick, Joyce M C Teng, Scott Guenthner, et al.
American Journal of Medical Genetics. Part A|March 13, 2016
RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndromeColleen F Macmurdo, Whitney Wooderchak-Donahue, Pinar Bayrak-Toydemir, et al.
JAMA Dermatology|July 17, 2014
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus StatementsJoyce M C Teng, Edward W Cowen, Mari Wataya-Kaneda, et al.
Medical Mycology Case Reports|September 29, 2021
<i>Prototheca wickerhamii</i> breast implant infection after reconstructive surgery: a new level of complexityJoanne S K Teh, Amalie E Wilke, Simon M Overstall, et al.
Biochemistry|June 12, 1998
A mutational analysis of binding interactions in an antigen-antibody protein-protein complexW Dall'Acqua, E R Goldman, W Lin, et al.
Journal of the American Academy of Dermatology|July 25, 2022
The CONTROL study: A randomized, double-blind vehicle-controlled phase 2b study of novel topical isotretinoin formulation demonstrates improvement in recessive X-linked and autosomal recessive lamellar congenital ichthyosisJoyce M C Teng, Christopher G Bunick, Scott Guenthner, et al.
JCO Clinical Cancer Informatics|June 16, 2026
Development of a Digital Phenotype for Immune-Related ColitisJasmine C Teng, Leon J Worth, Karin A Thursky, et al.
Pageof 31